Hana Pharm. Co., Ltd. Q3 operating profit KRW 6.4 billion, down 23.4% from a year earlier
AI summary · Not investment advice
Hana Pharm sold KRW 59.4 billion in Q3 and earned KRW 6.4 billion from its main business, down 23.4% from a year earlier and 12.4% from the previous quarter.
Operating profit · 3 months
KRW 6.4 billion
Key facts
- Revenue (3 months)
- KRW 59.4 billion
- Net income (3 months)
- KRW 4.6 billion
- Period
- Q3 (cumulative Jan 1, 2026 ~ Sep 30, 2026)
- Revenue (prior-year 3 months)
- KRW 63.8 billion
- Revenue (year to date)
- KRW 182.6 billion
- Operating profit (prior-year 3 months)
- KRW 8.3 billion
- Operating profit (year to date)
- KRW 20.8 billion
- Net income (prior-year 3 months)
- KRW -4.3 billionNet loss in the same period last year
- Net income (year to date)
- KRW 23.0 billion
Commentary
AI commentary · Not investment advice
What happened
Hanall Pharmaceutical reported its third-quarter results on a standalone basis. Sales for the latest 3 months were KRW 59.4 billion. That is 6.8% lower than a year earlier and 2.5% lower than the previous quarter. Sales for the year so far are KRW 182.6 billion.
In the company's terms
Operating profit (profit from the core business) for the 3 months was KRW 6.4 billion. That is 23.4% lower than a year earlier, when it was KRW 8.3 billion. It is also 12.4% lower than the previous quarter. Operating profit for the year so far is KRW 20.8 billion.
What changes for shareholders
Net income (the final profit after taxes and all other items) for the 3 months was KRW 4.6 billion, a swing back to profit. A year earlier, the same period had a net loss of KRW 4.3 billion. Net income is 45.7% lower than the previous quarter. Net income for the year so far is KRW 23.0 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
H